Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new class of medicines for intracellular targets. The company is advancing a portfolio of genetic medicines for neuromuscular and inherited retinal diseases, with lead oligonucleotide programs for Duchenne muscular dystrophy (DMD) and a collaboration with Vertex Pharmaceuticals for myotonic dystrophy type 1 (DM1). Entrada anticipates significant clinical milestones in 2026, including multiple clinical data readouts for its DMD programs and ongoing progress for its DM1 collaboration. The company fosters a high-energy, dedicated team environment and seeks colleagues ready to make a significant impact on patients' lives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director